Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C015262 |
1,6-hexamethylene diisocyanate |
NAT1 protein polymorphism results in increased susceptibility to 1,6-hexamethylene diisocyanate | increases response to substance | 11927838
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NAT1 mRNA | affects expression | 21346803
|
C012177 |
2-aminofluorene |
NAT1 protein results in increased acetylation of 2-aminofluorene | increases acetylation | 16003948 15796204 15627487
|
C012177 |
2-aminofluorene |
NAT1 protein results in increased metabolism of 2-aminofluorene | increases metabolic processing | 16815960
|
C012177 |
2-aminofluorene |
NAT1 protein results in increased acetylation of 2-aminofluorene | increases acetylation | 15796213
|
C003898 |
2-anisidine |
NAT1 protein results in increased activity of 2-anisidine | increases activity | 15450435
|
C075748 |
2-(bromoacetylamino)fluorene |
2-(bromoacetylamino)fluorene results in decreased activity of NAT1 protein | decreases activity | 14714730
|
C075748 |
2-(bromoacetylamino)fluorene |
2-(bromoacetylamino)fluorene results in decreased activity of and results in increased alkylation of NAT1 protein | decreases activity|increases alkylation | 15106881
|
C009501 |
2-tolidine |
NAT1 protein results in increased activity of 2-tolidine | increases activity | 15450435
|
C002385 |
3-morpholino-sydnonimine |
3-morpholino-sydnonimine results in decreased activity of NAT1 protein | decreases activity | 14672957
|
C117220 |
3-nitrobenzanthrone |
NAT1 protein results in increased activity of 3-nitrobenzanthrone | increases activity | 15805261
|
C009505 |
4,4'-diaminodiphenylmethane |
NAT1 protein results in increased acetylation of 4,4'-diaminodiphenylmethane | increases acetylation | 16192314
|
C005969 |
4,4'-diphenylmethane diisocyanate |
NAT1 protein polymorphism results in increased susceptibility to 4,4'-diphenylmethane diisocyanate | increases response to substance | 11927838
|
C013813 |
4-anisidine |
NAT1 protein results in increased acetylation of 4-anisidine | increases acetylation | 15627487
|
C006757 |
4-biphenylamine |
NAT1 protein results in increased acetylation of 4-biphenylamine | increases acetylation | 12088197
|
C006757 |
4-biphenylamine |
NAT1 protein results in increased activity of 4-biphenylamine | increases activity | 15450435
|
C006757 |
4-biphenylamine |
NAT1 protein results in increased metabolism of 4-biphenylamine | increases metabolic processing | 16815960
|
C023621 |
4-bromoaniline |
NAT1 protein results in increased acetylation of 4-bromoaniline | increases acetylation | 15627487
|
C004658 |
4-chloroaniline |
NAT1 protein results in increased acetylation of 4-chloroaniline | increases acetylation | 15627487
|
C013067 |
4-iodoaniline |
NAT1 protein results in increased acetylation of 4-iodoaniline | increases acetylation | 15627487
|
C029728 |
4-phenylenediamine |
NAT1 protein results in increased acetylation of 4-phenylenediamine | increases acetylation | 15350687
|
C017429 |
5-iodosalicylic acid |
5-iodosalicylic acid results in decreased activity of NAT1 protein | decreases activity | 15450435
|
C421010 |
9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole |
NAT1 protein affects the metabolism of 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | affects metabolic processing | 17067997
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NAT1 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of NAT1 protein | increases expression | 16538041
|
C518327 |
aloe emodin |
aloe emodin results in decreased expression of and results in decreased activity of NAT1 protein | decreases activity|decreases expression | 16314733
|
C518327 |
aloe emodin |
aloe emodin results in decreased expression of NAT1 mRNA | decreases expression | 16314733
|
D000588 |
Amines |
NAT1 protein results in increased acetylation of Amines | increases acetylation | 15122594
|
D010129 |
4-Aminobenzoic Acid |
NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid | increases acetylation | 14508638
|
D010129 |
4-Aminobenzoic Acid |
NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid | increases acetylation | 16003948 15627487 15880531
|
D015081 |
2-Naphthylamine |
NAT1 protein results in increased activity of 2-Naphthylamine | increases activity | 15450435
|
D019804 |
Mesalamine |
NAT1 protein results in increased acetylation of Mesalamine | increases acetylation | 15627487
|
D010131 |
Aminosalicylic Acid |
NAT1 protein results in increased acetylation of Aminosalicylic Acid | increases acetylation | 16003948 15627487
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NAT1 mRNA | affects expression | 16483693
|
D000814 |
Aniline Compounds |
NAT1 protein results in increased acetylation of Aniline Compounds analog | increases acetylation | 15627487
|
D001241 |
Aspirin |
Aspirin results in decreased activity of NAT1 protein | decreases activity | 15796213
|
C006680 |
baicalein |
baicalein results in decreased expression of NAT1 mRNA | decreases expression | 15796204
|
C006680 |
baicalein |
baicalein results in decreased expression of NAT1 protein | decreases expression | 15796204
|
C029876 |
benzidine |
NAT1 protein results in increased activity of benzidine | increases activity | 15450435
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NAT1 mRNA | increases expression | 19150397
|
C056005 |
bromoacetanilide |
bromoacetanilide results in decreased activity of NAT1 protein | decreases activity | 14714730
|
C056005 |
bromoacetanilide |
bromoacetanilide results in decreased activity of and results in increased alkylation of NAT1 protein | decreases activity|increases alkylation | 15106881
|
D002220 |
Carbamazepine |
Carbamazepine results in increased expression of NAT1 mRNA | increases expression | 17112801
|
D002338 |
Carotenoids |
NAT1 protein polymorphism affects the susceptibility to Carotenoids | affects response to substance | 15095308
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of NAT1 mRNA | increases expression | 17851650
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of NAT1 mRNA | affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NAT1 mRNA | decreases expression | 20106945
|
C010920 |
dihydrofolate |
dihydrofolate results in decreased activity of NAT1 protein | decreases activity | 16003948
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NAT1 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of NAT1 mRNA | increases expression | 19619570
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of NAT1 mRNA | decreases expression | 18035473
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene analog results in decreased activity of NAT1 protein | decreases activity | 15025497
|
D015073 |
2-Acetylaminofluorene |
NAT1 protein results in decreased acetylation of 2-Acetylaminofluorene | decreases acetylation | 15025497
|
D015073 |
2-Acetylaminofluorene |
NAT1 protein results in increased activity of 2-Acetylaminofluorene | increases activity | 15450435
|
D005492 |
Folic Acid |
Folic Acid results in decreased activity of NAT1 protein | decreases activity | 16003948
|
D005492 |
Folic Acid |
Folic Acid results in decreased activity of NAT1 protein modified form | decreases activity | 16003948
|
D005492 |
Folic Acid |
NAT1 protein results in increased acetylation of Folic Acid metabolite | increases acetylation | 15627487
|
D006202 |
Hair Dyes |
NAT1 protein polymorphism affects the susceptibility to Hair Dyes | affects response to substance | 12663508
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased activity of NAT1 protein | decreases activity | 15644493
|
D006881 |
Hydroxyacetylaminofluorene |
Hydroxyacetylaminofluorene results in decreased activity of NAT1 protein | decreases activity | 15720122
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of NAT1 mRNA | increases expression | 16184411
|
C533894 |
LG 100815 |
LG 100815 results in decreased expression of NAT1 mRNA | decreases expression | 16951191
|
D008727 |
Methotrexate |
Methotrexate results in decreased activity of NAT1 protein | decreases activity | 16003948
|
D008727 |
Methotrexate |
Methotrexate results in decreased activity of NAT1 protein modified form | decreases activity | 16003948
|
C001368 |
N-hydroxy-2-aminofluorene |
NAT1 protein results in increased acetylation of N-hydroxy-2-aminofluorene | increases acetylation | 12088197
|
C001365 |
N-hydroxy-4-acetylaminobiphenyl |
N-hydroxy-4-acetylaminobiphenyl results in decreased activity of NAT1 protein | decreases activity | 15720122
|
C001365 |
N-hydroxy-4-acetylaminobiphenyl |
N-hydroxy-4-acetylaminobiphenyl results in decreased activity of NAT1 protein | decreases activity | 15720122
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of NAT1 mRNA | increases expression | 17616710
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in decreased expression of NAT1 mRNA | decreases expression | 16951191
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased activity of NAT1 mRNA | decreases activity | 17564303
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased activity of NAT1 protein | decreases activity | 17564303
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of NAT1 mRNA | decreases expression | 15015580
|
D030421 |
Peroxynitrous Acid |
Peroxynitrous Acid results in decreased activity of NAT1 protein | decreases activity | 14672957 15644493
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
NAT1 protein results in increased acetylation of Polycyclic Hydrocarbons, Aromatic | increases acetylation | 15122594
|
D011342 |
Procainamide |
NAT1 protein results in increased acetylation of Procainamide | increases acetylation | 16003948
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of NAT1 mRNA | increases expression | 12016162
|
D013418 |
Sulfamethazine |
NAT1 protein results in increased acetylation of Sulfamethazine | increases acetylation | 16482518
|
D013467 |
Sulindac |
Sulindac results in decreased expression of NAT1 mRNA | decreases expression | 11828994
|
D013629 |
Tamoxifen |
NAT1 protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 20628863
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NAT1 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NAT1 mRNA | increases expression | 19619570
|
D014051 |
Toluene 2,4-Diisocyanate |
NAT1 gene polymorphism affects the susceptibility to Toluene 2,4-Diisocyanate | affects response to substance | 18447907
|
D014051 |
Toluene 2,4-Diisocyanate |
NAT1 protein polymorphism results in increased susceptibility to Toluene 2,4-Diisocyanate | increases response to substance | 11927838
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of NAT1 mRNA | increases expression | 19101580
|
C085514 |
wogonin |
wogonin results in decreased expression of NAT1 mRNA | decreases expression | 15816529
|
C085514 |
wogonin |
wogonin results in decreased expression of NAT1 protein | decreases expression | 15816529
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
10.82 | 14745880 |
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
10.82 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
15.15 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
15.15 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
15.15 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
15.15 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.34 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.91 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
7.26 | 17003819 16316344 16595132 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
7.26 | 7897758 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.02 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
6.02 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
6.02 | 11910360 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
16.69 | 10737359 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
16.69 | 3712494 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
16.69 | 16963246 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
16.69 | 11497255 |
MESH:D000236 |
Adenoma |
|
Sulindac |
16.69 | 10223192 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.35 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
2-aminofluorene |
8.68 | 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.68 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.03 | 19003578 12394442 15623613 11874996 17611924 11535846 16460482 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.04 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.24 | 16712894 17306315 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
4,4'-diphenylmethane diisocyanate |
5.35 | 7973495 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.71 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
4.01 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
4.01 | 15579461 17627676 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.57 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.38 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.18 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.05 | 17497229 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.23 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.24 | 10388637 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.51 | 2160914 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
4.39 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.39 | 17286800 |
MESH:D001249 |
Asthma |
|
1,6-hexamethylene diisocyanate |
7.14 | 10934080 |
MESH:D001249 |
Asthma |
|
4,4'-diphenylmethane diisocyanate |
7.14 | 8156442 11077012 6091945 10934080 15891530 10797510 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
7.14 | 17015710 20032816 170078 11467998 15590890 6091945 6091946 11742282 18394133 3040596 10934080 12684321 7684630 16210060 12762349 15855793 15590891 8156442 19187332 10797510 12585506 16792590 11077013 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.15 | 20485159 12372130 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.07 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.07 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.07 | 18558336 18316065 18396377 17507914 17688650 20603192 18177632 15238991 18940202 19232924 17157402 18775368 19460635 16609825 18985861 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.35 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.36 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
6.31 | 20046352 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
6.31 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.13 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.53 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.53 | 8888407 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
3.97 | 15867366 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.69 | 11207687 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.36 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
3.77 | 12524144 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
3.85 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
4-biphenylamine |
7.08 | 17671175 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
7.08 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
7.08 | 14630087 12948864 17261762 17018787 16675129 19861407 18497071 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
7.08 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
7.08 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
7.08 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
7.08 | 11325840 16244791 18223236 18323546 16115903 15136595 18234424 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
7.08 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
7.08 | 16818667 19189212 19289846 19115204 21138602 19142967 18997820 19189210 17440819 19059307 19487384 16202921 20390343 11161223 19200415 17242785 17049068 15565566 20065188 19084267 16873071 18815881 19288272 17893378 18821012 20544844 19410462 19221464 15668708 20135344 21152245 19155303 19103187 18351453 18984771 18629630 16273361 18855134 20859285 20005174 19011961 19244106 19066611 17261762 18425577 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
7.08 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
7.08 | 11921183 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
4,4'-diphenylmethane diisocyanate |
7.83 | 8156442 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
7.83 | 8156442 12507178 15590891 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.07 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.36 | 11239499 15625704 15141370 16537180 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.81 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.28 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
19.61 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
19.61 | 3581430 3084413 6705139 17761372 10737359 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-aminofluorene |
19.61 | 19052882 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
19.61 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
19.61 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.61 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
19.61 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
19.61 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
19.61 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
19.61 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.08 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.70 | 18791128 14736730 11352223 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
5.46 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
5.46 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
4.10 | 15482327 12636206 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.10 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.05 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
1.98 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
6.20 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.20 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.17 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
20.29 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4-biphenylamine |
20.29 | 15746073 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
20.29 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.29 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.29 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
20.29 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.43 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
2-aminofluorene |
8.25 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.25 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.51 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
6.22 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.22 | 19486331 |
MESH:D043171 |
Chromosomal Instability |
|
4-biphenylamine |
6.35 | 17671175 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
3.60 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
5.03 | 21254359 8946559 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.03 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D003093 |
Colitis, Ulcerative |
|
Mesalamine |
4.90 | 17339853 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
5.11 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
5.11 | 15625704 15786552 11260862 15936596 15637740 15963497 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
5.11 | 12902858 12458338 |
MESH:D015179 |
Colorectal Neoplasms |
|
4-biphenylamine |
7.18 | 17671175 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
7.18 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
7.18 | 17087956 17245555 16963246 17116713 16985020 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
7.18 | 17054584 12606626 18059344 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
7.18 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
7.18 | 11197048 18059344 10666051 11076880 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 17141729 14669216 |
MESH:D003233 |
Conjunctivitis, Allergic |
|
4,4'-diphenylmethane diisocyanate |
5.77 | 7973495 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.05 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
4.64 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
4.64 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.64 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.64 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.38 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
3.68 | 19747007 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.73 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
1,6-hexamethylene diisocyanate |
15.24 | 18759878 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
15.24 | 12868966 14531868 18759878 11906362 8156756 8970840 2524372 11298694 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diphenylmethane diisocyanate |
15.24 | 12868966 18759878 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4-phenylenediamine |
15.24 | 18759875 16533241 16823706 19470301 11906362 11298694 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
15.24 | 15491423 12956900 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
12.44 | 3621924 2952479 |
MESH:D003877 |
Dermatitis, Contact |
|
4-phenylenediamine |
12.44 | 11531941 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
12.44 | 17010967 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.51 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
3.87 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.87 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.00 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.00 | 19279558 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.56 | 12861449 17621415 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
3.20 | 7237001 7907874 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
4.81 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
3.98 | 16538176 16538175 20216337 15057820 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
14.85 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
14.85 | 9328219 7440962 6482804 18289764 18648102 6679447 11289319 16192314 8291058 18692083 9022650 1440618 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.85 | 12153990 2444490 11743745 19923254 17562736 16109766 12540782 17522070 19164858 16081117 14550746 16227642 16485898 11421492 19416960 11834606 19370779 19739265 16393943 11287661 19420014 12958197 18713872 15619225 16781746 10915739 11461765 19085960 14725611 15968718 12392966 18071297 11529661 17906064 10663392 16177239 10774834 12705907 11739529 14986274 12594235 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
14.85 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
14.85 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.85 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
14.85 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.44 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
6.74 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.74 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.50 | 18446180 16326151 18043480 17190690 12774134 16133044 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.53 | 11535926 11595431 17045617 16699067 11991626 10671773 17329845 11595415 17151854 17351913 17202747 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.45 | 1851702 |
MESH:D004487 |
Edema |
|
Aspirin |
8.32 | 17259670 |
MESH:D004487 |
Edema |
|
Indomethacin |
8.32 | 16100529 8985016 7907874 7990266 19703484 8273558 10653021 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.32 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.24 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
7.47 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.47 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
9.92 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
9.92 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
9.92 | 20544844 19155303 17893378 16202921 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
12.11 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
12.11 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
12.11 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
3.86 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.09 | 10567023 17763956 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.35 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
4,4'-diphenylmethane diisocyanate |
11.60 | 8156442 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
11.60 | 11298111 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
11.60 | 8156442 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
4.64 | 16415921 16538176 20485159 19915237 18855540 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
9.10 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
9.10 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
8.19 | 16628512 17116037 15008574 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
8.19 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
5.82 | 19620853 18234410 19700373 7988514 19439326 17178248 17465707 821787 20417680 9014606 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
5.82 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.04 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
9.60 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
9.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
8.74 | 15276670 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
8.74 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.07 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.57 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.57 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
14.57 | 11005569 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
14.57 | 16805852 15878914 15150132 16510608 15547721 15264214 16704527 15623463 15547733 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
14.57 | 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
14.57 | 12235107 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
4.82 | 20485159 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
4.84 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 11564622 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
5.10 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.77 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
9.77 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
9.77 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.81 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.82 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.22 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.51 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
4,4'-diphenylmethane diisocyanate |
8.06 | 7973495 |
MESH:D005334 |
Fever |
|
Indomethacin |
8.06 | 10431976 11852909 17627676 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.36 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
10.80 | 14745880 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
10.80 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
9.49 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.49 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.25 | 10962813 |
MESH:D005355 |
Fibrosis |
|
baicalein |
16.09 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
16.09 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
16.09 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.09 | 20067830 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.51 | 11298111 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
15.29 | 16983495 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
15.29 | 17171786 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
15.29 | 15046732 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.39 | 11910360 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.03 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.57 | 8708960 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.48 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
9.69 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
baicalein |
9.69 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
9.69 | 12870263 |
MESH:D005910 |
Glioma |
|
Indomethacin |
2.93 | 16487511 18371953 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.76 | 11849393 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.43 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.93 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.70 | 11248219 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.51 | 16518429 |
MESH:D006261 |
Headache |
|
Aspirin |
4.30 | 15240983 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
3.28 | 15482327 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
5.59 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.59 | 10048152 11294989 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
4.65 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
8.29 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
4-chloroaniline |
8.29 | 15200160 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.77 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.75 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
3.98 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
2.90 | 6705139 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.06 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.27 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.37 | 15709030 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
4.84 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.62 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.10 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.22 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.38 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.10 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.10 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
6.10 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.05 | 17883296 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.36 | 12524144 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
8.00 | 10459572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
8.00 | 16865747 16397167 16395265 16433478 16755160 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
3.57 | 17546600 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
9.02 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
9.02 | 18773962 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.04 | 11019492 10880147 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
3.96 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
3.96 | 18670907 18850075 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.36 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.70 | 10647630 10651667 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.71 | 16133044 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.55 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
aloe emodin |
15.06 | 19352036 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
15.06 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
15.06 | 3291741 12568917 7812673 |
MESH:D007249 |
Inflammation |
|
Sulindac |
15.06 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
15.06 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.06 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.52 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
3.70 | 11713966 11855677 17329856 11686837 18236018 15831440 15610444 10210152 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.07 | 10213222 10223192 12663524 12584176 12628509 12351151 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.39 | 11245490 12394442 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.71 | 15241188 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.36 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.36 | 10574470 16133968 18306037 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.78 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.70 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.70 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.70 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
14.70 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.70 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
3.69 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.67 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.67 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.67 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.67 | 18625569 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.50 | 9562676 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.37 | 11703811 12228301 10320625 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.43 | 10785260 15631656 16572323 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
3.56 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.56 | 16294345 17596541 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.71 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.05 | 17980183 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.68 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.22 | 17353645 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.05 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.31 | 14986274 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
7.05 | 9327722 15034207 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
7.05 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.06 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
4.06 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.06 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.06 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.44 | 16610002 16611625 11587558 19784758 12587719 12969438 19014921 19460945 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
5.44 | 16877991 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
5.44 | 16867024 14986274 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.67 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
24.18 | 18001218 14678523 16273603 11376686 10672840 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
2-aminofluorene |
24.18 | 20492335 20452335 19499222 19850985 |
MESH:D008113 |
Liver Neoplasms |
|
4-biphenylamine |
24.18 | 15761837 |
MESH:D008113 |
Liver Neoplasms |
|
9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole |
24.18 | 12970073 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
24.18 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Hydroxyacetylaminofluorene |
24.18 | 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
24.18 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
24.18 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.18 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
10.66 | 534488 1399818 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
10.66 | 3712494 598648 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4-biphenylamine |
10.66 | 11376689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.66 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.72 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
9.27 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
9.27 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
10.90 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
4-biphenylamine |
10.90 | 17671175 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
10.90 | 16537180 11497255 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Polycyclic Hydrocarbons, Aromatic |
10.90 | 10814675 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
10.90 | 17306315 17077188 16712894 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
10.90 | 15713900 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
10.90 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.90 | 19555203 11884234 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
5.14 | 16628512 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
5.14 | 17718048 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.47 | 17352296 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.56 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.12 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
4.51 | 16891317 17203775 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
4.51 | 19196723 19196722 16827153 14580682 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.45 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.45 | 19453300 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.04 | 16832597 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
6.03 | 16342250 12025231 12040289 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.03 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Sulindac |
6.03 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.03 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.53 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.93 | 19513568 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.47 | 9014606 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.12 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
4-biphenylamine |
4.81 | 12030840 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
9.91 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
9.91 | 11903285 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
9.91 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
3.48 | 12636206 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
4.63 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.21 | 14749477 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.44 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.75 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
3.25 | 12692751 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.49 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.77 | 16810080 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
4.82 | 20399394 |
MESH:D009325 |
Nausea |
|
Aspirin |
4.55 | 15240983 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.21 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
11.06 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
11.06 | 11053908 11239499 16537180 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
11.06 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
11.06 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.26 | 19410462 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.18 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
11.82 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
11.82 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
11.82 | 1670384 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.34 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.09 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.78 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.73 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
12.92 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
12.92 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
12.92 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
13.66 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
13.66 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
13.66 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
13.66 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
11.09 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
11.09 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
11.09 | 16850258 17266991 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
3.91 | 16322990 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.51 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
17.08 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
17.08 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diphenylmethane diisocyanate |
17.08 | 6091945 8156442 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
17.08 | 18394133 6091946 8156442 12585506 6091945 3040596 11077013 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.36 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
6.60 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
6.60 | 7009135 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.33 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
4.82 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
6.46 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
6.46 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
6.46 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
15.62 | 16870215 |
MESH:D010146 |
Pain |
|
Aspirin |
15.62 | 6995502 6363464 |
MESH:D010146 |
Pain |
|
Carbamazepine |
15.62 | 15215642 |
MESH:D010146 |
Pain |
|
Indomethacin |
15.62 | 17627676 3291741 17440234 13679232 |
MESH:D010146 |
Pain |
|
Sulindac |
15.62 | 3291741 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.02 | 12538197 18702446 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
3.09 | 11504793 16820089 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.33 | 15028970 17883296 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
7.22 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
7.22 | 12065085 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.05 | 16537180 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.06 | 16538176 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.55 | 12349958 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.27 | 17145499 17679678 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.05 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.59 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.50 | 11148446 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
4.89 | 11156591 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.25 | 17225004 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.10 | 15240983 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.81 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.94 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.67 | 12371664 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
4.52 | 9014606 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.49 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
12.64 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
12.64 | 11399792 11222880 11118676 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
12.64 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.30 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.29 | 17172428 16729912 17136230 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.29 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.29 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.57 | 11849393 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
10.40 | 9591791 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
10.40 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
4.98 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
4.98 | 17410198 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
4.96 | 14606601 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
8.60 | 15728788 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
8.60 | 17352296 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
4,4'-diphenylmethane diisocyanate |
5.03 | 7973495 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
4,4'-diphenylmethane diisocyanate |
7.71 | 16940033 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
7.71 | 7692837 20219652 16940033 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.22 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
4.46 | 18447907 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.88 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.57 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
7.42 | 12372130 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
7.42 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
4.62 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
4.85 | 19075512 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
3.44 | 16641680 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
3.44 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
7.31 | 18551238 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
7.31 | 9046859 15946322 16938433 19414003 9844417 16180713 16876388 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
7.31 | 11738929 3137016 16876388 1511512 14763951 15475178 11044598 17978042 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
4.63 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
3.05 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
7.45 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
7.45 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
7.45 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
4.48 | 19414003 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
4.85 | 19075512 19050374 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.63 | 16709447 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
4.84 | 16361298 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.39 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
7.83 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
7.83 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
3.88 | 12833885 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
4.58 | 15057820 18855540 19694795 20485159 19915237 16415921 16538176 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.77 | 15472012 16280098 10215738 18545984 10486359 10192188 17207306 18209964 15038085 17160473 16113693 17638125 16184426 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
4.09 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
4.09 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.09 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.09 | 18396642 18506536 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
3.03 | 11523592 16397915 15255614 1323529 11595431 12077510 12467913 16150113 17657623 18181030 18299717 17977527 18237397 12787963 18193104 18209962 12498302 15138204 16169175 11906479 14567935 18431645 17135157 16755016 16252198 16631530 11729361 15104355 12500499 17627676 16934674 10878458 11145282 10750652 11595415 10423059 18543354 17895592 18087811 17918041 18726076 17654042 |
MESH:D020521 |
Stroke |
|
Aspirin |
7.47 | 16403987 |
MESH:D020521 |
Stroke |
|
Folic Acid |
7.47 | 16517955 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.42 | 9562676 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.16 | 16930453 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
3.96 | 17672075 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.24 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.66 | 3712494 1399818 6587162 6582329 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
5.66 | 18791128 14736730 11352223 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.02 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.57 | 17262798 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.25 | 17380554 10574470 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.87 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
marker/mechanism |
|
| 16003747 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
23.14 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
23.14 | 1399818 15867355 15289314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
23.14 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.14 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4-biphenylamine |
23.14 | 6654951 11144890 12376482 17671175 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
benzidine |
23.14 | 12500666 16003747 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
23.14 | 11723127 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
23.14 | 17572228 16712894 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.01 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.67 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
6.92 | 10982225 |
MESH:D014581 |
Urticaria |
|
Aspirin |
6.92 | 10982225 20485159 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.20 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
3.99 | 18645019 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.32 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.78 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.93 | 12125929 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.09 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.59 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.78 | 17120751 |